Mission
PREMIER will provide investigators with access to biospecimens, expertise, training, and pilot funding to advance precision medicine studies in rheumatic diseases.
UCSF is a national leader in the area of precision medicine. PREMIER, Precision Medicine in Rheumatology is an NIH/NIAMS funded Center at UCSF with the overarching goal of facilitating and enhancing precision medicine studies in rheumatic diseases. PREMIER can provide investigators with resources to enable studies that will better define rheumatic disease subgroups with different etiologies, prognoses, or treatment responses. Core resources can provide access to clinical data and biospecimens along with new technologies for cellular, molecular and genetic phenotyping and bioinformatics analyses.
Funding Opportunities
PREMIER has several funding opportunities throughout the year, including pilot grants for established and junior investigators managed by the Resource Allocation Program (RAP), and Core Usage Grants managed by PREMIER. More details are available on the Funding Opportunities page of our website.
Events
PREMIER Genomics and Molecular Resources Core: Biospecimens, Data, and Advanced Processing Technology available for Precision Medicine Studies
Held on May 14, 2018 featuring speakers: Lindsey A. Criswell, MD, MPH, DSc,Pui-Yan Kwok, MD, PhD, Jimmie Ye, PhD, and Alex Marson, MD, PhD. Archived lecture is available here. You can watch this video to learn how PREMIER GMR Core can advance your research and how you can take advantage of the extensive patient sample collection/ new technologies/ new approaches to studying autoimmune diseases.